Showing results (121-130 of 272) with videos related to
Sort By:
Pageof 28
Oncotarget|March 16, 2018
The IL-6/STAT3 pathway upregulates microRNA-125b expression in hepatitis C virus infectionChia-Yen Dai, Yi-Shan Tsai, Wen-Wen Chou, et al.The Kaohsiung Journal of Medical Sciences|October 6, 2020
Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancyMing-Lun Yeh, Hsing-Tao Kuo, Ching-I Huang, et al.Medicine|October 27, 2015
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized StudyMing-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2017
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in TaiwanMeng-Hsuan Hsieh, Ming-Lun Yeh, Tung-Hung Su, et al.Viruses|November 11, 2022
Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVRPo-Yao Hsu, Po-Cheng Liang, Ching-I Huang, et al.The Kaohsiung Journal of Medical Sciences|February 16, 2024
Third vaccine boosters and anti-S-IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinomaChih-Wen Wang, Chung-Feng Huang, Tyng-Yuan Jang, et al.Journal of Hepatology|November 9, 2010
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trialJee-Fu Huang, Ming-Lung Yu, Chung-Feng Huang, et al.Journal of Gastroenterology and Hepatology|August 3, 2019
Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevirChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.Journal of Molecular Medicine (Berlin, Germany)|October 23, 2015
MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replicationWen-Wen Chou, Chung-Feng Huang, Ming-Lun Yeh, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 21, 2020
Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrenceShu-Chi Wang, Chia-Yang Li, Wen-Tsan Chang, et al.Pageof 28